Shares of Diploma PLC (LON:DPLM – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is GBX 5,634.29.
A number of research firms have weighed in on DPLM. Deutsche Bank Aktiengesellschaft lifted their target price on Diploma from GBX 6,000 to GBX 6,200 and gave the company a “buy” rating in a report on Wednesday, January 14th. Peel Hunt reiterated a “buy” rating and issued a GBX 6,150 price objective on shares of Diploma in a research report on Friday, December 19th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 6,350 price objective on shares of Diploma in a research note on Wednesday, November 19th.
Check Out Our Latest Stock Report on Diploma
Diploma Stock Up 0.4%
Diploma (LON:DPLM – Get Free Report) last announced its quarterly earnings data on Monday, December 8th. The company reported GBX 176 EPS for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. On average, equities analysts forecast that Diploma will post 163.7995512 EPS for the current year.
Insider Activity
In related news, insider Geraldine Huse acquired 750 shares of the firm’s stock in a transaction that occurred on Wednesday, November 19th. The shares were bought at an average cost of GBX 3,997 per share, for a total transaction of £29,977.50. Also, insider Wilson Ng purchased 410 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was bought at an average cost of GBX 5,369 per share, for a total transaction of £22,012.90. In the last quarter, insiders have purchased 2,012 shares of company stock worth $9,993,580. Company insiders own 1.14% of the company’s stock.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
- Five stocks we like better than Diploma
- The AI Arms Race Has a New Contender: VWAV
- The DoD just got a new drone supplier
- Trump’s next major investment
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
